> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Patient-Focused Drug Development Meeting for Neuropathic Pain
- URL: https://www.fdaweb.com/patient-focused-drug-development-meeting-for-neuropathic-pain/
- Published: 2016-04-18T12:00:00.000Z
- Updated: 2026-09-14T20:55:32.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135408

*Federal Register* Notice: FDA will hold a public meeting 6/10 and is making an opportunity for public comment on Patient-Focused Drug Development for neuropathic pain associated with peripheral neuropathies. The public meeting is intended to allow FDA to obtain patient perspectives on the impact of neuropathic pain associated with peripheral neuropathies, patient views on treatment approaches, and decision factors taken into account when selecting a treatment. The meeting will be held from 10 a.m. to 4 p.m. Registration to attend the meeting must be received by 6/3\. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-04-18/pdf/2016-08881.pdf?ref=fdaweb.com)